BioAesthetics Corporation
Durham, NC · Founded 2017 · CIK 0001716873 · Medtech · Private
Aesthetic skin and hair treatment services using advanced lifting, tightening, and density-boosting techniques
bio-aesthetics.com →- Grants
- $3.1M
- 6 awards
- Sector median: 1
- Raised
- $5.0M
- 2 Form D · Sep 2020
- 72 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $4,532,850 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Novel Acellular Grafts Containing Rifampin and Minocycline for Single-Stage Reconstruction of Stage II-III Pressure Ulcers | $251,208 | |
| Federal grant | Department of Health and Human Services · Phase I · PHMB-Impregnated Acellular Biologic Grafts for Treatment of Third-Degree Burns | $308,069 | |
| Federal grant | Department of Health and Human Services · Phase I · Polymer-Strengthened AcellularBiologically-Derived Grafts for Pelvic Organ Prolapse | $255,971 | |
| Federal grant | Department of Health and Human Services · Phase I · Infection Fighting Polymer Strengthened Biologic Grafts for Abdominal Wall Repair | $258,684 | |
| Federal grant | Department of Health and Human Services · Phase II · PHMB-Impregnated Acellular Biologic Grafts for Treatment of Third-Degree Burns | $874,179 | |
| Federal grant | Department of Health and Human Services · Phase II · PHMB-Impregnated Acellular Biologic Grafts for Treatment of Third-Degree Burns | $1,130,527 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1139 | TAURUS DIAGNOSTICS, INC | — | — |
| 1140 | SFC FLUIDICS, INC. | — | $2.1M |
| 1141 | RODO MEDICAL, INC. | — | $7.7M |
| 1142 | BioAesthetics Corporation | — | $5.0M |
| 1143 | Nirvana Sciences, Inc. | — | $1.7M |
| 1144 | ALGOMETRX INC | — | $1.9M |
| 1145 | SS Innovations International, Inc. | — | $22M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sandra CoufalDirector
- Yi GuDirector
- William HeimDirector · Executive Officer
- Nicholas PashosDirector · Executive Officer
- M. PrestonDirector
- Martha PrestonDirector
Patents
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
- Poland Syndrome And Methods Of Treatmentapplication
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
- Poland Syndrome And Methods Of Treatmentapplication
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
- Poland Syndrome And Methods Of Treatmentapplication
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
- Polymer-permeated Grafts And Methods Of Making And Using The Sameapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.